BIOMAT Database Logo BIOMAT Database Logo

Synthesis and acetylcholinesterase inhibitory activity of Mannich base derivatives flavokawain B. 2014

Hao-Ran Liu, and Xue-Qin Huang, and Ding-Hui Lou, and Xian-Jun Liu, and Wu-Kun Liu, and Qiu-An Wang
College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China.

A novel series of flavokawain B derivatives, chalcone Mannich bases (4-10) were designed, synthesized, characterized, and evaluated for the inhibition activity against acetylcholinesterase (AChE). Biological results revealed that four compounds displayed potent activities against AChE with IC50 values below 20μM. Moreover, the most promising compound 8 was 2-fold more active than rivastigmine, a well-known AChE inhibitor. The logP values of 4-10 were around 2 which indicated that they were sufficiently lipophilic to pass blood brain barriers in vivo. Enzyme kinetic study suggested that the inhibition mechanism of compound 8 was a mixed-type inhibition. Meanwhile, the molecular docking showed that this compound can both bind with the catalytic site and the periphery of AChE.

UI MeSH Term Description Entries
D008352 Mannich Bases Ketonic amines prepared from the condensation of a ketone with formaldehyde and ammonia or a primary or secondary amine. A Mannich base can act as the equivalent of an alpha,beta unsaturated ketone in synthesis or can be reduced to form physiologically active amino alcohols. Mannich Base,Base, Mannich,Bases, Mannich
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Hao-Ran Liu, and Xue-Qin Huang, and Ding-Hui Lou, and Xian-Jun Liu, and Wu-Kun Liu, and Qiu-An Wang
Synthesis and Antiproliferative Activity of Thioxoflavones Mannich Base Derivatives.
July 2017, Archiv der Pharmazie,
Hao-Ran Liu, and Xue-Qin Huang, and Ding-Hui Lou, and Xian-Jun Liu, and Wu-Kun Liu, and Qiu-An Wang
Synthesis and antitumor activity evaluation of coumarin Mannich base derivatives.
January 2024, Chemical biology & drug design,
Hao-Ran Liu, and Xue-Qin Huang, and Ding-Hui Lou, and Xian-Jun Liu, and Wu-Kun Liu, and Qiu-An Wang
Artemisinin derivatives bearing Mannich base group: synthesis and antimalarial activity.
October 2003, Bioorganic & medicinal chemistry,
Hao-Ran Liu, and Xue-Qin Huang, and Ding-Hui Lou, and Xian-Jun Liu, and Wu-Kun Liu, and Qiu-An Wang
Biocidal activity of some Mannich base cationic derivatives.
November 2005, Bioorganic & medicinal chemistry,
Hao-Ran Liu, and Xue-Qin Huang, and Ding-Hui Lou, and Xian-Jun Liu, and Wu-Kun Liu, and Qiu-An Wang
Synthesis of benzofuran derivatives via rearrangement and their inhibitory activity on acetylcholinesterase.
November 2010, Molecules (Basel, Switzerland),
Hao-Ran Liu, and Xue-Qin Huang, and Ding-Hui Lou, and Xian-Jun Liu, and Wu-Kun Liu, and Qiu-An Wang
Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity.
September 2015, Bioorganic & medicinal chemistry,
Hao-Ran Liu, and Xue-Qin Huang, and Ding-Hui Lou, and Xian-Jun Liu, and Wu-Kun Liu, and Qiu-An Wang
Synthesis and antinociceptive activity of novel mannich base derivatives of some new fused 3,5-pyrazolidinedione.
January 2014, Journal of advanced pharmaceutical technology & research,
Hao-Ran Liu, and Xue-Qin Huang, and Ding-Hui Lou, and Xian-Jun Liu, and Wu-Kun Liu, and Qiu-An Wang
Synthesis and antioxidant activity of novel Mannich base of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan.
November 2013, Bioorganic & medicinal chemistry,
Hao-Ran Liu, and Xue-Qin Huang, and Ding-Hui Lou, and Xian-Jun Liu, and Wu-Kun Liu, and Qiu-An Wang
Palladium-catalyzed synthesis and acetylcholinesterase inhibitory activity evaluation of 1-arylhuperzine A derivatives.
November 2023, Journal of Asian natural products research,
Hao-Ran Liu, and Xue-Qin Huang, and Ding-Hui Lou, and Xian-Jun Liu, and Wu-Kun Liu, and Qiu-An Wang
Synthesis and antiproliferative activity of pterostilbene and 3′-methoxy pterostilbene Mannich base derivatives against Hela cells.
November 2015, Molecular diversity,
Copied contents to your clipboard!